Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?

Figures & data

Figure 1 FDG PET/CT of patient 1. Upper line showing clivus, liver and rib lesions before therapy and lower line showing the same lesions after the administration of 6 cycles of Doxorubicin plus Olaratumab. Arrows highlight the lesions.

Figure 2 CT scans of patient 2. Upper line showing liver and lung lesions before therapy and lower line showing the same lesions after the administration of 6 cycles of Doxorubicin plus Olaratumab. Arrows highlight the lesions.